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L-2,3-diaminopropionic acid (L-Dap) is an amino acid
that is a precursor of antibiotics and staphyloferrin B
a siderophore produced by Staphylococcus aureus.
SbnA and SbnB are encoded by the staphyloferrin
B biosynthetic gene cluster and are implicated in
L-Dap biosynthesis. We demonstrate here that
SbnA uses PLP and substrates O-phospho-L-serine
and L-glutamate to produce a metabolite N-(1-
amino-1-carboxyl-2-ethyl)-glutamic acid (ACEGA).
SbnB is shown to use NAD+ to oxidatively hydrolyze
ACEGA to yield a-ketoglutarate and L-Dap. Also, we
describe crystal structures of SbnB in complex with
NADH and ACEGA as well as with NAD+ and a-keto-
glutarate to reveal the residues required for substrate
binding, oxidation, and hydrolysis. SbnA and SbnB
contribute to the iron sparing response of S. aureus
that enables staphyloferrin B biosynthesis in the
absence of an active tricarboxylic acid cycle.
INTRODUCTION
Iron is required for the growth of most organisms, and patho-
genic bacteria invest considerable resources into scavenging
iron from their environment (Wandersman and Delepelaire,
2004). Staphylococcus aureus is a serious bacterial pathogen
that employs several iron uptake strategies to circumvent
host defenses while fulfilling its nutritional iron requirements
(Hammer and Skaar, 2011). Siderophores are low molecular
weight ferric iron chelators that are assembled and secreted
by many bacteria to scavenge for iron from host proteins.
S. aureus synthesizes two carboxylate-type siderophores
staphyloferrin A (SA) and staphyloferrin B (SB) under iron
deprivation (Drechsel et al., 1993; Konetschny-Rapp et al.,
1990). The enzymes responsible for SA biosynthesis and
export have been identified and functionally characterized
(Beasley et al., 2009; Cotton et al., 2009). Likewise, the locus
responsible for SB synthesis and export has been identified
and the functions of several enzymes have been demonstrated
(Cheung et al., 2009; Dale et al., 2004a). Although both sidero-
phores are functionally similar, only SB is required for normal
growth in the presence of mammalian serum (Beasley et al.,
2009, 2011b) and inactivation of the SB biosynthetic operonChemistry & Biology 21, 3was impaired for virulence in a mouse infection model (Dale
et al., 2004a).
The sbn gene cluster is composed of nine genes (sbnA–sbnI)
that are responsible for SB biosynthesis and export (Dale et al.,
2004a). SB is assembled from one molecule each of citrate
and a-ketoglutarate (a-KG) and two molecules of L-2,3-
diaminopropionic acid (L-Dap). Four enzymes are required for
SB synthesis: SbnC, SbnE, and SbnF are nonribosomal peptide
synthesis independent synthetases, and SbnH is an enzyme
that decarboxylates the biosynthetic intermediate, b-citryl-2,3-
diaminopropionic acid (Cheung et al., 2009). The sbn operon
also encodes three enzymes that synthesize essential SB pre-
cursors. Recently, SbnG, a predicted class II aldolase, was
demonstrated to be a distinct type of citrate synthase capable
of producing citrate from oxaloacetate and acetyl coenzyme A
(Cheung et al., 2012). Additionally, strains with deletions of either
sbnA or sbnB are unable to produce SB (Beasley et al., 2011a).
Supplementing media with L-Dap restores normal SB produc-
tion in these strains, implicating SbnA and SbnB in L-Dap syn-
thesis (Beasley et al., 2011a); however, the reaction pathway
and substrates were unknown.
L-Dap is an amino acid produced by numerous plants and
bacteria. L-Dap is a potent inhibitor of PLP-dependent enzymes
associated with glycolysis and amino acid biosynthesis (Garcia-
Hernandez and Kun, 1957; Kalyani et al., 2012) and has been
demonstrated to inhibit the growth of Corynebacterium
diphtheriae (Kjerulfjensen and Schmidt, 1945). Typically, L-Dap
is incorporated into secondary metabolites as exemplified by
the synthesis of neurotoxin b-N-oxalyl-l-a,b-diaminopropionic
acid in the seeds of the legume Lathyrus sativus (Malathi et al.,
1970). L-Dap is a key precursor in the synthesis of many antibi-
otics such as viomycin and capreomycin, two structurally related
antituberculosis drugs that belong to the tuberactinomycin
family of nonribosomal peptide antibiotics (Felnagle et al.,
2007; Thomas et al., 2003). Furthermore, chemically synthesized
L-Dap-based compounds have been successfully used as scav-
engers of a-oxoaldehydes (Audic et al., 2013) and as efficient
gene delivery systems (Lan et al., 2010). Despite the prevalence
of L-Dap in nature, an L-Dap biosynthetic pathway has yet to be
experimentally defined.
SbnA and SbnB are homologous to VioB and VioK, respec-
tively, two enzymes in the viomycin biosynthetic pathway that
were originally proposed to be involved in L-Dap synthesis
based on bioinformatic analyses (Thomas et al., 2003). VioK is
predicted to be an ornithine cyclodeaminase (OCD) that converts
L-ornithine to L-proline and an ammonium ion using NAD+ as a79–388, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 379
Figure 1. SbnA Condenses OPS and
L-Glutamate to Generate ACEGA
(A) UV-visible absorption spectra of SbnA (black
line), SbnA in complex with OPS (blue line) and
after the addition of excess L-glutamate (red line).
The spectra were recorded with 30 mM SbnA,
30 mM OPS, and 3 mM L-glutamate.
(B) SbnA catalyzes the increased release of
inorganic phosphate from OPS in the presence of
L-glutamate. After 2 min, 2 mM of various amino
acids were added to the SbnA reaction mixture. All
reactions were performed in triplicate.
(C) LC-ESI-MS analysis of the SbnA reaction for
product formation. A mass ion species of 235
corresponded to the predicted mass of ACEGA
was identified. All mass spectra were recorded
with retention times between 4.6–5.5 min.
See also Figure S1.
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(OASS) that is thought to catalyze a b-replacement reaction of
the L-serine hydroxyl group, using the ammonium ion liberated
from the previous VioK reaction to generate L-Dap (Thomas
et al., 2003). Previous precursor labeling studies of viomycin and
capreomycin have revealed L-serine as a probable precursor for
L-Dap (Carter et al., 1974; Wang and Gould, 1993). Based on
sequence homology, SbnA and SbnB are annotated as OASS
and OCD, respectively. Four possible schemes were proposed
for L-Dap biosynthesis from various metabolites including
L-ornithine and O-acetyl-L-serine (Beasley et al., 2011a).
In this study, we characterized the biochemical properties of
SbnA and SbnB to elucidate the L-Dap biosynthetic pathway.
We demonstrate that SbnA performs a b-replacement reaction
dependent upon O-phospho-L-serine (OPS) and L-glutamate
to produce a serine-glutamate conjugate N-(1-amino-1-
carboxy-2-ethyl)-glutamic acid (ACEGA). Oxidative hydrolysis
of ACEGA catalyzed by SbnB is shown to release a-KG and
L-Dap, thereby providing a biological source for two of the three
precursors required for SB biosynthesis in S. aureus. These find-
ings reveal an experimentally validated pathway for L-Dap
biosynthesis in nature and an adaptive metabolic response in
S. aureus to negate the requirement for tricarboxylic acid cycle
metabolites in SB biosynthesis during iron deprivation.
RESULTS
SbnA Produces ACEGA from O-Phospho-L-Serine and
L-Glutamate
SbnA is homologous to the Class II PLP-dependent family of
enzymes and shares an 36% amino acid sequence identity
with structurally characterized OASS (Heine et al., 2004). An
absorption maxima at 412 nm was observed in electronic
spectra of recombinantly expressed SbnA (Figure 1A), which380 Chemistry & Biology 21, 379–388, March 20, 2014 ª2014 Elsevier Ltd All rights reservedwas attributed to an internal Schiff base
formed between the PLP cofactor and
an active site lysine residue. Despite
homology to OASS, addition of excess
O-acetyl-L-serine (OAS) or L-serine did
not alter SbnA absorption spectra, evenafter 5min of incubation, signifying that the expected aminoacry-
late external aldimine did not form in SbnA (Figure S1 available
online). Another SbnA homolog, CysM from Mycobacterium
tuberculosis (34% sequence identity), is an O-phospho-L-serine
sulfhydrylase (OPSS) that forms part of an alternative cysteine
biosynthetic pathway (Agren et al., 2008). Adding OPS to SbnA
caused a rapid change in electronic spectra with the appearance
of peaks at 324 and 467 nm, characteristic of the formation of an
external aminoacrylate intermediate coupled with phosphate
release (Figure 1A). This intermediate was susceptible to nucle-
ophilic attack by an amine donor to either form L-Dap directly or
via an intermediate (Beasley et al., 2011a). To identify the amine
donor, SbnA turnover was measured by monitoring phosphate
release from OPS in the presence of various amino acids. Only
addition of L-glutamate resulted in a dramatic increase in phos-
phate release (Figure 1B). Also, adding excess L-glutamate to
the aminoacrylate aldimine form of SbnA resulted in a return to
the resting state as observed by the single peak at 412 nm in
electronic spectra (Figure 1A).
Based on the identified optimal substrates OPS and
L-glutamate, the resulting product was proposed to be an
L-glutamate-L-serine conjugate ACEGA defined by a secondary
amine formed between the serine b-carbon and L-glutamate
amino nitrogen (Figure 2). SbnA reaction mixtures were analyzed
using liquid chromatography-electrospray ionization (LC-ESI)
mass spectroscopy in positive ion mode. Only the full reaction
containing SbnA, OPS and L-glutamate yielded a dominant
mass ion at [M + H]+ = 235 Da, which was similar to the predicted
mass of 234 Da for ACEGA (Figure 1C). When either substrate or
protein was omitted the 235 Da mass ion peak was not detected
(Figure 1C). The structure of ACEGAwas verified by NMR using a
combination of 1H, 13C, HSQC, and HMBC analyses (Figure S2).
All expected cross-peaks for ACEGA were observed in the
HMBC spectra with all protons showing correlation to every
Figure 2. Proposed Biosynthetic Pathway
for L-Dap by SbnA and SbnB
The structure of the intermediate N-(1-amino-
1-carboxy-2-ethyl)-glutamic acid (ACEGA) was
determined by NMR.
See also Figure S2 and Table S2.
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L-glutamate from the reaction and glycerol, a possible contam-
inant from dialysis, were also observed. Chemical shifts for
ACEGA obtained from the 1H, 13C spectra are shown in Table
S1. These data are in agreement with the suggestion that
SbnA utilizes OPS and L-glutamate as substrates in a reaction
that generates ACEGA.
SbnB Hydrolyzes ACEGA to Form L-Dap and a-KG
SbnB is homologous to the m-crystallin/OCD protein family,
which includes a subset of alanine dehydrogenases. These
enzymes utilize NAD+ as either a cofactor (OCD), or substrate
(alanine dehydrogenase). SB biosynthesis requires both SbnA
and SbnB to produce L-Dap (Beasley et al., 2011a) and we
hypothesized that ACEGA generated from SbnA is a substrate
of SbnB, alongwithNAD+, to produce L-Dap anda-KG (Figure 2).
To test this, SbnB was incubated with SbnA, OPS, L-glutamate,
andNAD+ and activity wasmeasured by absorption at 340 nm as
an indicator for the generation of NADH. Omitting L-glutamate or
OPS from the reaction negated the conversion of NAD+ to NADH
(Figure 3A). Because ACEGA is not commercially available, the
reverse SbnB reaction was analyzed using L-Dap, a-KG, and
NADH as substrates. NADH consumption was measured by
the decrease in absorption at 340 nm, which did not occur in
the absence of L-Dap, a-KG, or NADH (Figure 3B). To demon-
strate that a-KG was consumed in the reverse reaction, the
a-KG concentration was measured using 2,4-dinitrophenylhy-
drazine (Dnph), a colorimetric assay for detecting ketone and
aldehyde functional groups in solution. SbnB reactions with
L-Dap, a-KG, and NADH resulted in the rapid consumption of
a-KG (Figure 3C). The products of the SbnB reverse reaction
were analyzed by LC-ESI mass spectroscopy, revealing a prom-
inent peak at [M + H]+ = 235 Da, identical to the mass derived
from the SbnA forward reaction and attributed to ACEGA (Fig-
ure 3D). These results support that in the forward reaction of
SbnB, ACEGA and NAD+ are consumed to produce L-Dap,
a-KG, and NADH.
L-Dap and a-KG Generated from SbnA and SbnB Are
Substrates for SB Biosynthesis
SB can be synthesized in vitro using purified synthetases: SbnC,
SbnE, and SbnF, alongwith a decarboxylase, SbnH, and the pre-
cursor substrates: citrate, a-KG, and L-Dap (Cheung et al., 2009;
Grigg et al., 2010). Because SbnA and SbnB can produce two of
the required substrates for SB biosynthesis (L-Dap and a-KG),
we reformulated the complete SB synthesis reaction by addingChemistry & Biology 21, 379–388, March 20, 2014SbnA, SbnB, OPS, L-glutamate, and
NAD+ to an in vitro reaction mixture in
place of L-Dap and a-KG. Reactions con-
taining SbnA, SbnB, OPS, L-glutamate,
and NAD+ produced a chrome azural S(CAS)-positive result, demonstrating iron-chelating activity.
Furthermore, the CAS-positive reaction mixtures were capable
of promoting S. aureus growth in disc diffusion assays (Figure 4).
To verify whether SB was indeed synthesized, we used a previ-
ously described S. aureus strain with a chromosomal deletion of
the lone SB receptor, SirA (Dale et al., 2004b). Both the CAS pos-
itive samples from our assay and from a positive control reaction
mixture that included both L-Dap and a-KG failed to support
growth of the sirA deletion S. aureus strain (Figure S3). These
results indicate that both L-Dap and a-KG generated from
SbnA and SbnB can be incorporated to the complete bio-
synthetic pathway to form a functional SB siderophore.
Structures of SbnB Complexes
The crystal structure of selenomethionine (SeMet)-labeled SbnB
was solved by anomalous dispersion methods and refined to
2.1 A˚ resolution (Table S1). Subsequently, structures were
solved of SbnB-NAD+ in complex with malonate, citrate, and
a-KG, as well as SbnB-NADH in complex with ACEGA to re-
solutions of 1.85 A˚ to 2.36 A˚. All of the SbnB crystals were
of the space group P41212 with a single molecule in the
asymmetric unit.
The SbnB monomer was composed of an NAD binding
domain containing a seven-stranded parallel b sheet surrounded
by helices in a classic dinucleotide-binding fold and a dimeriza-
tion domain that was made almost entirely of a six-stranded
antiparallel b sheet (Figure 5A). A SbnB dimer could be recon-
structed by the application of crystallographic symmetry (Fig-
ure 5B). Analysis by the program PISA (Krissinel and Henrick,
2007) showed that the interaction interface was at the large anti-
parallel b sheets burying 5,450 A˚2 of surface area. In solution
SbnB (38 kDa monomer) exists primarily as a dimer with
mass estimates of 81 kDa and 71 kDa as determined by dynamic
and multi-angle light scattering, respectively (Figure S4D).
Comparison of the apo-SbnB structure with the ligand bound
complexes revealed that NAD+/NADH was bound at full occu-
pancy in a preformed rigid pocket (Figure S4A). Each SbnB
monomer contains an NAD+/NADH bound at the base of the in-
terdomain channel between the NAD binding and dimerization
domains (Figure S4A). A modest difference between the apo-
SbnB and SbnB-NAD+ structures was a subtle shift of the b4/
b5 loop between the dimerization domains, highlighted by the
1.1 A˚ shift of Lys89 Ca. The loop displacement was likely the
result of a hydrogen bond formed between Arg94 Nε and Nh at
the N-terminal end of b5 NAD
+ phosphate oxygen atoms. In the
SbnB-NAD+ structure, the planar nicotinamide ring confirmsª2014 Elsevier Ltd All rights reserved 381
Figure 3. SbnB Degrades ACEGA to
Generate L-Dap and a-KG
(A) SbnB activity was monitored via the generation
of NADH. SbnB reactions were coupled with
SbnA, OPS, and L-glutamate. After 2min, a total of
50 nmol of NAD+ was added to each reaction
mixture.
(B) The SbnB reaction was reversible in the
presence of NADH, L-Dap, and a-KG. SbnB
activity was measured by monitoring the con-
sumption of NADH.
(C) a-KG detection by the 2,4-dinitrophenylhy-
drazine assay. Aliquots of the reaction mixtures
were removed every minute and assayed for total
ketone levels. Error bars indicate SD from the
mean for three replicates.
(D) LC-ESI-MS analysis of the full SbnB reverse
reaction for product formation and confirmation of
the reaction intermediate. A mass ion species
of 235 corresponded to the predicted mass of
ACEGA was identified. The mass spectrum
was recorded with a retention time between 7.3–
8.9 min.
Chemistry & Biology
L-2,3-Diaminopropionic Acid BiosynthesisNAD+ was in the oxidized state as compared to the SbnB-NADH
structure, in which the ring was distorted from planarity (Figures
5C and 5D). The entry and exit channels for substrate and prod-
ucts were 12 A˚ long and oriented on opposite faces of the
dimer (Figures 5B and S4B). The substrate binding pocket adja-
cent to the nicotinamide ring re face was observed to have a pre-
dominantly positive electrostatic potential with three arginines
(Arg60, Arg94, and Arg122) and one lysine (Lys78) (Figures
S4B and S4C). This electrostatic tuning was well-suited to bindFigure 4. L-Dap and a-KG Generated from SbnA and SbnB Can Be
Used by Sbn Siderophore Synthetases to Create SB In Vitro
Disk diffusion growth assays were performed with TMS agar plates seeded
with S. aureus. SB enzyme reaction mixtures were spotted onto sterile paper
disks and the diameter of growth was measured 48 hr after incubation. The full
reaction sample contains enzymes SbnA and SbnB and the Staphyloferrin B
sample is the positive control containing a-KG and L-Dap. Error bars were
recorded as the SD for the mean from three replicates. The dashed line
represents the diameter of the paper disk. The experiment was repeated using
a S. aureus sirAmutant as a negative control; SirA is the lone receptor for ferric
bound SB. See also Figure S3.
382 Chemistry & Biology 21, 379–388, March 20, 2014 ª2014 Elsevienegatively charged substrates and crystals grown in the pres-
ence of malonate and citrate had clear density for the respective
molecule in the active site. In both structures, a terminal carbox-
ylate was anchored by a salt bridge to Arg94, pointing to its role
in stabilizing a terminal substrate carboxylate (Figure S4C).
The product of the SbnA reaction, ACEGA, was soaked into
SbnB crystals in the presence of NAD+ or NADH. Soaking with
NAD+ and ACEGA resulted in observed electron density in the
active site pocket that was modeled as an a-KG molecule at
80% occupancy and an average B-factor of 42 A˚2, indicating
that SbnB in crystal form remains catalytically active (Figure 5C).
Density for a L-Dap molecule was not observed. A structural
superposition shows that a-KG binds in a similar manner to
both malonate and citrate such that their terminal carboxylates
interact with Arg94 (Figure S4C). NADH was soaked into SbnB
crystals in conjunction with ACEGA and electron density for
intact ACEGA was clearly visible and was modeled in at 87%
occupancywith an average B-factor of 45 A˚2 (Figure 5D). Overall,
no large structural differences were observed between SbnB-
NADH-ACEGA and SbnB-NAD+-a-KG, which were superim-
posed with a root-mean-square deviation (rmsd) of 0.5 A˚ over
all atoms. ACEGA was bound in the active site in an extended
conformation parallel to the nicotinamide ring, such that the
L-glutamate-derived portion was at the base of the pocket and
the OPS-derived moiety was directed toward the solvent chan-
nel (Figure 5D). The side chain of Arg122 forms a bridged interac-
tion with both ACEGA and the amide group in NADH. A similar
interaction was also observed in the SbnB-NAD+ structures in
complex with citrate and a-KG (Figure S4C). An additional
hydrogen bond interaction between the terminal carboxylate of
a-KG and Lys45 was observed in the SbnB-NAD+-a-KG struc-
ture. The L-glutamate-derived portion of ACEGA, like a-KG
and citrate in the other SbnB complexes, formed hydrogen
bonds to Lys78, Arg94, and Arg122 (Figures 5C, 5D, and S4D).
The spatial distribution of Lys78, Arg94, and Arg122 appearsr Ltd All rights reserved
Figure 5. Structure of SbnB
(A) The overall fold of apo-SbnBwith the backbone
shown as a schematic diagram. Dimerization and
NAD binding domains colored green and orange,
respectively.
(B) The SbnB dimer as obtained through crystal-
lographic symmetry. Individual SbnB monomers
are colored blue and green.
(C) a-KG bound into the active site of SbnB in the
presence of NAD+. Omit difference electron den-
sity is shown as a graymesh contoured at 1.0 s. All
residues and ligands are shown as sticks and the
dashed line represents the distance between the
C2 atom of a-KG and C4 atom of NAD+.
(D) ACEGA bound into the active site of SbnB in
the presence of NADH. Omit difference electron
density is shown as a gray mesh contoured at 1.0
s. All residues and ligands are shown as sticks and
the dashed line represents the distance between
the C2 atom of ACEGA and C4 atom of NADH.
See also Figure S4 and Table S2.
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atoms long. Additionally, Arg60 was observed to interact with
both L-glutamate and OPS-derived portions of ACEGA. ACEGA
was aligned such that the C2 atom from the L-glutamate-derived
portion was 3.8 A˚ from the NADH C4 atom (Figure 5D). In
contrast, the a-KG C2 and NADH C4 atoms were offset and
the distance elongated to 4.0 A˚ due to the addition of a ketone,
which repositions the a-KG terminal carboxylate to form
hydrogen bonds with Lys45 and Arg122 (Figure 5C). The ketone
in a-KGwas observed to bewithin hydrogen bonding distance to
Lys78 (Figure 5C). In summary, the binding sites for ACEGA,
a-KG, citrate, and malonate largely overlap and many of the
same residues in SbnB (Figures 5C, 5D, and S4D) are involved
in hydrogen bond interactions with the bound substrates;
however, only in ACEGA is the C2 atom aligned for optimal
hydride transfer.
DISCUSSION
In this study, we demonstrated that SbnA and SbnB function in
tandem to produce L-Dap and a-KG from OPS and L-glutamate
(Figure 2). Through LC-MS and X-ray crystallographic experi-
ments, we demonstrated that ACEGA is an intermediate in the
L-Dap biosynthetic pathway. Previously, based on sequence
similarity SbnA was annotated as an OASS that displaced the
acetyl group of OAS with an ammonium ion to produce L-Dap
in one step (Thomas et al., 2003). Our results show that OPS
and L-glutamate are substrates for SbnA and form an amino
acid ACEGA. Indeed, SbnA sharesmoderate sequence similarity
to CysM a characterized OPSS; however, instead of a sulfurChemistry & Biology 21, 379–388, March 20, 2014nucleophile, SbnA utilizes nitrogen from
L-glutamate, distinguishing this enzyme
from all known sulfhydrylases. Interest-
ingly, no reaction is observed for SbnA
with OAS in contrast to several character-
ized OPSS (Agren et al., 2008; Ishikawa
et al., 2010). Thus, although SbnA is
clearly homologous to the OAS/OPSSsuperfamily, SbnA is the archetype of an enzyme family that con-
denses OPS with potentially any amino acid with the release of
inorganic phosphate. Detailed analysis of the substrate speci-
ficity and the overall reaction mechanism for SbnA are currently
under investigation.
SbnB catalyzes the second step of the L-Dap pathway to
generate L-Dap and a-KG from the intermediate ACEGA using
NAD+ as a substrate (Figure 2). SbnB is homologous to the
m-crystallin/OCD protein family suggesting that it functions
similar to either ornithine cyclodeaminases or NAD+-dependent
amino acid dehydrogenases. Our analysis revealed that SbnB
uses NAD+ as a substrate, which is a reaction more closely
related to that of the NAD+-dependent amino acid dehydroge-
nases. A well-characterized example is alanine dehydrogenase
(AlaDH) from Archaeoglobus fulgidus (Gallagher et al., 2004).
Superposition of the active site of SbnB with those from AlaDH
and OCD is presented in Figure 6. Four residues that form the
base of the active site are conserved in all three enzymes:
Lys45, Lys78, Arg122, and Asp313 (SbnB numbering). Two
of these residues, Lys78 and Arg122, hydrogen bond to the
terminal carboxylate of substrates bound to SbnB and OCD
to align the a-carbon atom of the substrate with NAD+. SbnB
differs from these homologs in that the active site in has
been expanded to accommodate a larger substrate than
alanine or ornithine. A unique feature of SbnB is the presence
of Arg94 forms a salt bridge to the terminal carboxylate of
ACEGA.
Based on the structural homology in the active sites of SbnB
with AlaDH, we propose a mechanism for SbnB based on anal-
ogy to the mechanism proposed for AlaDH. In this mechanism,ª2014 Elsevier Ltd All rights reserved 383
Figure 6. Structural Overlay of Homologs to
SbnB
Structural overlays were assembled for SbnB
against two homologs (A) alanine dehydrogenase
(tan) from Archaeoglobus fulgidus (Protein Data
Bank [PDB] ID: 1OMO) and (B) ornithine cyclo-
deaminase (purple) from Pseudomonas putida
(PDB ID: 1X7D). SbnB ligands and residues were
colored green with the exception of NADH, which
was colored white. All active site residues and
ligands are shown as sticks.
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ACEGA to NAD+, followed by a water-mediated nucleophilic
attack to generate a-KG and L-Dap (Figure 7). The identity of
the base has not been defined in AlaDH or SbnB. Inspection of
the superposition of the SbnB structure with that of AlaDH
suggests two candidates: Lys45 and Lys78 (Figure 6A). Of these
residues, Lys45 is not conserved in OCD (Figure 6B); however,
an external base may not be required in the cyclization reaction
to form proline. As noted herein, Lys78 participated in a
hydrogen bond interaction with the terminal carboxylate of the
substrate limiting a dual role. Lys45 is more distant from the
substrate and an alternate side-chain conformation is required
for proton access. Future site-directed mutagenesis studies
may assist in defining a possible catalytic role to Lys45.
Currently, the L-Dap biosynthetic pathway has been identified
in the one siderophore as characterized in this paper; however,
L-Dap biosynthetic genes are found in a handful of known
antibiotics (Beasley et al., 2011a). Two related L-Dap containing
tuberactinomycin antibiotics, viomycin and capreomycin, are
used to treat drug resistant M. tuberculosis infections (Felnagle
et al., 2007; Thomas et al., 2003). Notably, the synthesis
of viomycin and capreomycin involve a-KG-dependent oxy-
genases VioC and CmnC, respectively (Yin and Zabriskie,
2004). Thus, the homologs of SbnA and SbnB in these pathways
would also supply both precursors.
Identification of OPS and L-glutamate as substrates for
L-Dap synthesis enabled us to explore how SB biosynthesis
integrates with primary metabolism. S. aureus grown in the
presence of human serum or blood undergoes a global meta-
bolic reorganization that includes responding to low iron stress
by the ferric uptake repressor (Fur) regulatory network (Xiong
et al., 2000). Low iron stress induces an ‘‘iron sparing
response’’ in S. aureus that downregulates many iron-depen-
dent metabolic pathways, including the tricarboxylic acid
(TCA) cycle. Simultaneously, the glycolytic pathway is upregu-
lated leading to the overproduction of pyruvate and lactate
(Allard et al., 2006; Friedman et al., 2006). Consequently, both
citrate and a-KG generated from the TCA cycle would be in
limited supply for SB biosynthesis. The recent identification of
SbnG as a citrate synthase provided a partial explanation of
the paradox for SB biosynthesis under iron deprivation (Cheung
et al., 2012). Now that an alternative pathway is known for a-KG
production, in addition to L-Dap, a complete set of precursors384 Chemistry & Biology 21, 379–388, March 20, 2014 ª2014 Elsevier Ltd All rights reservedfor the SB biosynthetic pathway is avail-
able in the absence of a functioning TCA
cycle.Themetabolites OPS and L-glutamate are likely to be available
in S. aureus in the absence of a TCA cycle under iron restriction.
Analysis of the S. aureus transcriptome data under iron depriva-
tion (Malachowa et al., 2011) provides an explanation for how
OPS and L-glutamate are supplied for SB biosynthesis. The
biosynthetic pathway (serAC) for OPS biosynthesis from
L-glutamate and the glycolytic intermediate glycerate 3-phos-
phate is upregulated. Second, also upregulated is a pathway
(gltBD) for L-glutamate biosynthesis from L-glutamine and
a-KG. Analysis of these pathways revealed that L-glutamine
and glycerate 3-phosphate yield a stoichiometric amount of
L-DAP and a-KG (Figure S5). Because SB biosynthesis requires
2 L-DAP and 1 a-KG, the excess a-KG produced could be used
to generate additional L-glutamate. Tracing back SB precursor
pathways reveal glucose and L-glutamine to be the source for
production of the basic building blocks required to generate
SB. NMR studies of human serum revealed that glucose and
L-glutamine are two of the four most abundant metabolites
available (Psychogios et al., 2011).
The genes serAC and gltBD encode enzymes in the pathways
to produce OPS and L-glutamate and form part of the CodY
regulon in S. aureus (Majerczyk et al., 2010; Pohl et al., 2009).
CodY, a global regulator for adapting to nutrient limitations and
virulence, is primarily found in Gram positive bacteria. In
S. aureus, the CodY regulon appears to complement sidero-
phore production through increasing production of metabolic
precursors. Also, microarray analyses show that CodY coregu-
lates iron uptake systems in Bacillus anthracis along with Fur
(Chateau et al., 2011; van Schaik et al., 2009). S. aureus appears
to have adapted to take advantage of available host nutrients as
a strategy to produce SB without the need of a functioning TCA
cycle to satisfy its iron requirements.
SIGNIFICANCE
Upon iron-restriction in the human host, Staphylococcus
aureus employs an iron-sparing response that favors energy
production by glycolysis over the TCA cycle. Paradoxically,
staphyloferrin B is a siderophore produced to acquire iron
and requires the TCA cycle intermediate a-ketoglutarate
as well as L-2,3-diaminopropionic as precursors. The
enzymes SbnA and SbnB encoded within the staphyloferrin
B biosynthetic gene cluster source the glycolysis-derived
Figure 7. Proposed Catalytic Mechanism
for Oxidative Hydrolysis of ACEGA to
Generate L-Dap and a-KG in SbnB
The first step involves a hydride transfer from the
C2 atom of the L-glutamate-derived portion of
ACEGA to NAD+. A water molecule attacks the
resulting imine at the C2 atom, facilitated by the
base, B, to form a carbinolamine intermediate.
Collapse of the carbinolamine intermediate results
in the formation of a-KG and L-Dap. See also
Figure S5.
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duce both a-ketoglutarate and L-2,3-diaminopropionic via
a metabolite N-(1-amino-1-carboxyl-2-ethyl)-glutamic acid.
Together with SbnG, which produces citrate, SbnA and
SbnB free staphyloferrin biosynthesis frommetabolic limita-
tions impose by the iron-sparing response of S. aureus.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
sbnA and sbnB were amplified from S. aureus Newman genomic DNA and
cloned into pET28a with an N-terminal 6x-His tag and transformed into
Escherichia coli BL21(DE3). Cultures were inoculated into 2x YT media at
30C, grown to an optical density of 0.8, and expression was induced by
adding 0.3 mM isopropyl b-D-thiogalactopyranoside and grown overnight
at 25C. Cells were lysed in 50 mM Tris pH 8.0, 100 mM NaCl using an
EmulsiFlex-C5 homogenizer (Avestin), and cell debris was removed by centri-
fugation. Protein was purified with a HisTrap HP column (GE Healthcare),
eluted with imidazole and dialyzed into 20 mM Tris pH 8.0. The 6x-His tag
was removed by thrombin digestion for 3 hr at room temperature. SbnA
and SbnB were further purified using a Source 15Q column equilibrated with
20 mM Tris pH 8.0 and eluted with a linear NaCl gradient to 500 mM. SbnA
and SbnB were dialyzed into 20 mM Tris pH 8.0 and concentrated to
20 mg/ml. Selenomethionine (SeMet)-labeled SbnB was produced by previ-
ously described method (Van Duyne et al., 1993) and purified as described
above. Protein preparations for LC-MS, spectroscopic assays and SbnB-
NAD+-a-KG and SbnB-NADH-ACEGA structures were purified as described
above with the addition of 2 mM Tris(2-carboxyethyl)phosphine (TCEP) in all
buffer solutions and 100 mM KCl in the final buffer solution.
Crystallization and Structure Determination
Four different conditions were used to obtain crystals of SbnB and of
complexes with malonate, citrate, a-KG, and ACEGA. SeMet-labeled SbnBChemistry & Biology 21, 379–388, March 20, 2014crystals were obtained by hanging drop vapor
diffusion in drops containing 1 ml protein solution
and 1 ml of reservoir solution (0.1 M Bis-tris pH
6.5, 0.2 M LiSO4 and 25% PEG 3350). Malonate
and citrate-bound SbnB structures were deter-
mined from crystals grown from 1 ml of protein
solution with 1 ml of either 2.4 M sodium malonate
pH 7.0, or 1.8 M ammonium citrate tribasic pH 7.0,
respectively. Crystals were soaked for 5 min in
mother liquor supplemented with 30% glycerol
and flash frozen in liquid nitrogen. For ACEGA
soaking experiments, SbnB crystals were pro-
duced by the sitting drop vapor diffusion method
in 0.2 M MgCl2, 0.1 M HEPES pH 7.5 and 29%–
33% PEG 400. Substrates (5 mM final concen-
tration of NAD+, NADH, or ACEGA) were added
directly to crystals and incubated for 30 min
and flash frozen directly in liquid nitrogen.
Single wavelength anomalous diffraction data
for SeMet SbnB crystals were collected on beam-line 7-1 at the Stanford Synchrotron Radiation Light Source (SSRL). Data were
integrated and scaled using HKL2000. Preliminary phasing andmodel building
was performed using the programs, Solve (Terwilliger and Berendzen, 1999)
and Resolve (Terwilliger, 2000, 2003) at 2.5 A˚ resolution. Eight of ten possible
selenium sites were identified with a figure of merit of 0.66 following density
modification. Phases were extended to 2.1 A˚ resolution using DM (Cowtan,
1994) and 290 of 332 residues were built and placed using ArpWarp (Perrakis
et al., 1999). The structurewasmanually edited usingCoot (Emsley et al., 2010)
and refinedwith Refmac (Murshudov et al., 1997) from theCCP4 program suite
(Winn et al., 2011) using TLS refinement with six TLS groups. The final model
comprises all residues excluding Met1 and a loop 51–55, which could not be
resolved in the electron density map. Data for the SbnB-NAD+-malonate and
SbnB-NAD+-citrate complexes were collected using SSRL beamline 7-1.
Structures were phased using MolRep and manually edited using Coot
(Emsley et al., 2010) and refined with Refmac5 (Murshudov et al., 1997).
Data from substrate soaked SbnB crystals were collected using a Saturn
944+ CCD detector on a Rigaku MicroMax-007 HF X-ray generator. Data
were integrated and scaled using HKL3000. The data sets were solved using
Phaser-MR (McCoy et al., 2007) from Phenix (Adams et al., 2010) and the
structures were refined with phenix.refine using TLS refinement. Data collec-
tion and refinement statistics are provided in Table S2. The electrostatic poten-
tial of SbnB was calculated by the Adaptive Poisson-Boltzmann Solver
software (Baker et al., 2001).
Determination of Oligomeric State in Solution
Purified SbnB was dialyzed into 50 mM Tris pH 8.0, 200 mMNaCl and filtered.
SbnB solutions were analyzed by dynamic light scattering in a Wyatt DynaPro
plate reader (Wyatt Technologies). Data were the average over five readings
from three independent samples. Additionally, SbnB was analyzed by size
exclusion chromatography multi-angular light scattering. SbnB was concen-
trated to 5 mg/ml in 50 mM Tris pH 8.0, 100 mM KCl, and 2 mM TCEP and
injected (100 ml) into a HPLC 1260 Infinity LC (Agilent Technologies) attached
toaSuperdex 20010/300column (GEHealthcare)with aflow rate of 0.2ml/min.
Data was collected using a miniDAWN TREOS multi-angle static lightª2014 Elsevier Ltd All rights reserved 385
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nologies). Analysis was performed by ASTRA6 program (Wyatt Technologies).
Phosphate Release Assay
Inorganic phosphate release was measured by a continuous spectroscopic
assay as previously described (Webb, 1992). The conditions used were
50 mM Tris pH 8.0, 1 mM MgCl2, 5 mM DTT, 100 mM KCl, 0.5 U purine nucle-
oside phosphorylase, 200 mM 2-amino-6-mercapto-7-methylpurine riboside
(MESG), and 500 nMSbnA. All reactions were performed at room temperature.
The presubstrate mixture was incubated for 5 min to remove contaminating
inorganic phosphate and blanked. All data was collected on a Varian Cary
50 UV-Vis spectrophotometer. Continuous measurement recorded at
360 nm was started after the addition of 1 mM OPS. At 2 min, various com-
pounds were added at a concentration of 2 mM and the assay was run for a
total of 20 min. A total of three replicates were collected.
Spectrophotometry Analysis
Electronic absorbance spectra of SbnA were collected on a Varian Cary
50 UV-Vis spectrophotometer. The spectra of SbnA-PLP were recorded at a
concentration of 20 mM in 50 mM Tris pH 8.0, 100 mM KCl, and 2 mM TCEP
at room temperature. Spectra of the SbnA aminoacrylate aldimine complex
were recorded immediately after the addition of 30 mM OPS. To demonstrate
the return of the resting state, 3 mM L-glutamate was added to the SbnA-PLP/
OPS mixture, incubated for 10 min and then recorded. To test if SbnA bound
O-acetyl-L-serine or L-serine, electronic spectra were collected after 5 min
incubation.
NADH Assay
NADH generation was monitored continuously at 340 nm for 20 min. at room
temperature on a Varian Cary 50 UV-Vis spectrophotometer. Coupled reac-
tions contained 50 mM Tris pH 8.0, 100 mM KCl, 2 mM TCEP, 10 mM SbnA,
10 mM SbnB, 1 mM OPS, 1 mM L-glutamate, and 100 mM NAD+. After 2 min
incubation and blanking, NAD+ was added to each reaction mixture and the
absorbance monitored for a further 18 min. An extinction coefficient of 6,220
M1cm1 was used for NADH. For NADH consumption assays the reaction
mixtures were run for 5 min. Reactions contained 50 mM Tris pH 8.0,
100 mM KCl, 2 mM TCEP, 1 mM SbnB, 1 mM L-Dap, 1 mM a-KG, and
200 mM NADH. All reactions were done in triplicate.
a-KG Assay
The assays performed were a modification on a previously described 2,4-
dinitrophenylhydrazine assay protocol (Else et al., 1988). To summarize,
500 ml reactions were performed with 10 mM SbnB, 1 mM a-KG, 1 mM L-Dap,
1.5 mM NADH in 50 mM Tris pH 8.0, 2 mM TCEP at room temperature. At
1 min intervals, 25 ml aliquots were removed and quenched with 450 ml of
0.1 M HCl containing 0.5 mM 2,4-dinitrophenylhydrazine (Dnph) and 25 ml
dH2O. Mixtures were incubated for 10 min. To each quenched reaction,
500 ml of 2 M NaOH was added and incubated for a further 5 min. All reaction
mixturesweremeasured at 450 nmon aVarianCary 50UV-Vis spectrophotom-
eter. An extinction coefficient of 12,500 M1cm1 was used for the 2,4-
dinitrophenylhydrazone derivative covalently linked to a-KG. All reactions
wereblankedwithaDnphsolution (0.1MHCl) containingonlydH2O.Thecontrol
blank was also quenched with an equivalent amount of 2 M NaOH prior to use.
Mass Spectrometry Analysis
SbnA and SbnB reactions were performed in dH2O for 1 hr at room tempera-
ture. Proteins were removed by centrifugation at 14,000 3 g for 20 min. The
filtrates were then injected onto a LC-MS system comprised of an HP 1100
HPLC with a Waters Alantis HILIC column (100 3 3.0, 3.0 mm, 100 A˚) coupled
to an Esquire LC-Ion Trap (Bruker). Separation was done at a flow rate of
550 ml/min with a gradient that started at 35% B and increased to 50% B
over 12 min. Solvent A was acetonitrile and Solvent B was 20 mM ammonium
formate. Analysis was performed with electrospray ionization in positive ion
mode with a scanning range 50 to 700 mass-to-charge ratio (m/z).
NMR Analysis
SbnA reactions were performed in 50 mM potassium phosphate pH 8.0 with
10 mM OPS and 10 mM L-glutamate overnight at room temperature. SbnA386 Chemistry & Biology 21, 379–388, March 20, 2014 ª2014 Elseviewas removed from the reaction by centrifugation through a Nanosep 3K
Omega spin column (Pall) at 14,000 3 g for 20 min. NMR analysis of reaction
product (10 mM ACEGA in 50 mM phosphate/10% D2O pH 8.0) was
performed at 25C on a Bruker Avance 600 MHz spectrometer with a cryo-
probe. 1H spectrum was obtained using water-presaturation. 13C, 1H-13C
HSQC, and 1H-13C HMBC spectra were measured using standard methods
provided by TopSpin software (Bruker).
In Vitro SB Biosynthesis Reactions
One pot reactions were assembled that incorporated SbnA, SbnB, OPS,
L-glutamate, and NAD+ in place of a-KG and L-Dap. Enzyme reactions, 1 ml
in volume, consisted of SbnA, SbnB, SbnC, SbnE, SbnF, and SbnH (10 mM
each), 5 mM ATP, 0.5 mM MgCl2, 0.5 mM PLP, 2 mM sodium citrate, 2 mM
OPS, 2 mM L-glutamate, and 2 mM NAD+ in 50 mM HEPES pH 8.0 containing
2mM TCEP. A positive control for staphyloferrin B synthesis was included that
contained both a-KG and L-Dap. All reactions were incubated for 16 hr at room
temperature in the dark. Following incubation, reaction mixtures were spun
down with a Nanosep 3KOmega spin column (Pall) to remove all Sbn proteins.
Filtrates were stored in the dark at 4C.
Siderophore detection was performed using the chrome azurol S (CAS)
shuttle solution. Fifty microliter aliquots of SB reaction mixture were removed
and diluted with 450 ml dH2O followed by the addition of 500 ml CAS shuttle
solution. The mixture was incubated at room temperature in the dark for 1 hr
and quantitated as previously described (Beasley et al., 2009).
Disk diffusion bioassays were performed as previously described (Beasley
et al., 2009; Cheung et al., 2012). A total of 5 ml SB reactionmixtures were com-
bined with 5 ml of 50 mM FeCl3 and spotted onto sterile paper disks that were
placed onto Tris-minimal-succinate agar seededwith 13 104S. aureus perml.
Bacteria used were S. aureus strain Newman and S. aureus RN6390 isogenic
sirAmutant. Plates were incubated at 37C for 36 hr and growth wasmeasured
by the diameter of the growth halo surrounding each disk.
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